ClinConnect ClinConnect Logo
Search / Trial NCT06164678

Vaping Cessation Using the Ottawa Model for Smoking Cessation Among E-Cigarette Users

Launched by OTTAWA HEART INSTITUTE RESEARCH CORPORATION · Dec 1, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying whether a structured program, including counseling and Nicotine Replacement Therapy (NRT), can help people who use e-cigarettes quit vaping. Researchers want to see if this approach is more effective than just counseling alone. Participants in the study will first attend a counseling session where they will learn tips for quitting and track their vaping habits for a week. After that, they will be randomly placed into one of two groups—one receiving the full program with NRT and the other receiving counseling only. Follow-up assessments will occur at 1, 3, 6, and 12 months to see how many people successfully quit vaping.

To be eligible for the study, participants need to be at least 18 years old, live in Ontario, and regularly use e-cigarettes (at least once a week for the past month). Those with certain cognitive or psychiatric issues, individuals living in care facilities, or those already enrolled in other cessation programs won’t be able to participate. This trial is important because it aims to fill a gap in resources for e-cigarette users who want to quit, especially since current vaping trends, particularly among young people, raise health concerns.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • \>18 years of age or older
  • Ontario resident
  • Ability to speak English or French
  • Regular use of e-cigarette (vaping at least once per week for the past four weeks)
  • Exclusion Criteria:
  • Cognitive impairment or acute psychiatric illness that would alter their ability to participate
  • Being institutionalized at a retirement home, nursing home or long-term care facility
  • Participating in another smoking or vaping cessation program
  • Allergy or intolerance to NRT

About Ottawa Heart Institute Research Corporation

The Ottawa Heart Institute Research Corporation is a leading clinical research organization dedicated to advancing cardiovascular medicine through innovative research and clinical trials. Affiliated with the renowned University of Ottawa Heart Institute, the corporation focuses on conducting high-quality, ethically-driven studies that aim to improve patient outcomes and enhance understanding of heart-related diseases. With a commitment to collaboration and excellence, the organization engages multidisciplinary teams of researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective therapies and interventions for cardiovascular health.

Locations

Ottawa, Ontario, Canada

Patients applied

0 patients applied

Trial Officials

Hassan Mir, MD

Principal Investigator

Ottawa Heart Institute Research Corporation

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported